SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ABT - Abbott Labs
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
328 12 0 ABT
Emcee:  Masood Ahmed Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
303Chris, "Anesta is also developing other oral transmucosal products for quitFrostman-7/17/2000
302Cephalon to buy Anesta for $444 mln By Stephanie O'Brien, CBS.MarketWatch.cSkywatcher-7/17/2000
301Chris, Congratulations on ABT! Looking forward to new developments. FrostmanFrostman-7/12/2000
300Abbott Reports Increase in Sales, Earnings in Second Quarter, First Half ABBOTT Skywatcher-7/12/2000
299Abbott Profits Up 6.2 Percent ABBOTT PARK, Ill. (Reuters) - Health-care producSkywatcher-7/12/2000
298Abbott Laboratories Named One of the Nation's Best Companies for Minorities Skywatcher-7/6/2000
297Abbott Laboratories Named One of the Nation's Best Companies for Minorities Skywatcher-7/6/2000
296Abbott in cancer drug licensing deal with Eisai NORTH CHICAGO, Ill., July 5 (ReuSkywatcher-7/5/2000
295Abbott seeks European approval of AIDS/HIV drug ABBOTT PARK, Ill., July 5 (ReutSkywatcher-7/5/2000
294Chris, I'd guess so! "100% - Buy" FrostmanFrostman-7/1/2000
293This page is always interesting and certainly the 100% opinions across the boardSkywatcher-7/1/2000
292Chris, The deal between Abbott and Vivus is for Europe, Japan, etc. The FDA apprFrostman-6/30/2000
291Quite a turnaround from down 1 1/4 to up 1/2...guess many people really had someSkywatcher-6/30/2000
290TAP withdraws impotence drug application LAKE FOREST, Ill., June 30 (Reuters) - Skywatcher-6/30/2000
289 Abbott Laboratories and Battelle Pulmonary Therapeutics Announce License AgreemSkywatcher-6/29/2000
288 Preliminary Data Support Further Development Of NPS 1776 for Neurological DisorSkywatcher-6/28/2000
287 Individual Investor Brandywine Drunk on Success By: Craig Schneider (06/26/00) Skywatcher-6/26/2000
286 worldlyinvestor.com Sector of the Day A Twofer Biotech Deal By Nadine Wong, BioSkywatcher-6/23/2000
285 Abbott Labs to market Vivus impotence drugs overseas MOUNTAIN VIEW, Calif., JunSkywatcher-6/19/2000
284 Chris, This should clear up the ABT/VVUS partnership rumor. ragingbull.com FrFrostman-6/19/2000
283 Hill-Rom Company, a Hillenbrand Industries Company Inc., Announces New E-CommerSkywatcher-6/19/2000
282 Question about paclitaxel and NPRO ... Hi - I am long NPRO. As you may or may John McCarthy-6/16/2000
281 Price was the highest of the day...still trading in a narrow range today...I suSkywatcher-6/16/2000
280 IF you're sure it was a buy, it is most encouraging! Do you guys think UprFrostman-6/16/2000
279 MILLION PLUS block went through at the opening today... That's a LOT OF CASSkywatcher-6/16/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News